肝纤维化:基于钆塞酸增强肝胆期MR图像的深度卷积神经网络分期
本回顾性研究纳入训练组534例和测试组100例有病理参考标准的患者,利用钆塞酸增强肝胆期MR图像训练深度卷积神经网络模型输出纤维化深度学习评分(FDL评分)。FDL评分与纤维化分期显著相关(Spearman相关系数0.63,P<.001),诊断F4、F3、F2期的ROC曲线下面积分别为0.84、0.84、0.85,模型在肝纤维化分期中表现出高诊断性能。
要点
- FDL评分与肝纤维化分期显著相关(Spearman相关系数0.63,P<.001)。
- 测试组诊断F4、F3、F2期的AUC分别为0.84、0.84、0.85。
- 模型基于钆塞酸增强肝胆期MR图像及静态磁场、乙肝和丙肝病毒检测结果输入。
核心结论
- 深度卷积神经网络模型在肝纤维化分期中表现出高诊断性能。
研究设计与样本
- 回顾性研究,训练组534例、测试组100例,参考标准为MR检查前6个月内活检或手术标本的肝纤维化分期。
- 输入数据包括肝胆期MR图像、成像设备静态磁场、乙肝和丙肝病毒检测结果(阳性或阴性)。
- 训练组纤维化分期F0、F1、F2、F3、F4分别为54、53、81、113、233例,平均年龄67.4±9.7岁,男388例、女146例。
- 训练组三个不同层面的MR图像扩增90倍(旋转、平移、亮度和对比度变化),共生成144180幅图像,以监督学习最小化FDL评分与纤维化分期的差异。
- 测试组纤维化分期F0、F1、F2、F3、F4分别为10、10、15、20、45例,平均年龄66.8岁±10.7,男71例、女29例,采用ROC分析评估模型性能。
诊断标准与关键数值
- FDL评分与纤维化分期显著相关,Spearman秩相关系数0.63(P<.001)。
- 测试组诊断F4期纤维化的ROC曲线下面积为0.84。
- 测试组诊断F3期纤维化的ROC曲线下面积为0.84。
- 测试组诊断F2期纤维化的ROC曲线下面积为0.85。
临床应用与阅片要点
- 原文结论为深度卷积神经网络模型在肝纤维化分期中表现出高诊断性能,未据此给出具体阅片或报告建议。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To investigate the performance of a deep convolutional neural network (DCNN) model in the staging of liver fibrosis using gadoxetic acid-enhanced hepatobiliary phase magnetic resonance (MR) imaging. Materials and Methods This retrospective study included patients for whom input data (hepatobiliary phase MR images, static magnetic field of the imaging unit, and hepatitis B and C virus testing results available, either positive or negative) and reference standard data (liver fibrosis stage evaluated from biopsy or surgical specimens obtained within 6 months of the MR examinations) were available were assigned to the training (534 patients) or the test (100 patients) group. For the training group (54, 53, 81, 113, and 233 patients with fibrosis stages F0, F1, F2, F3, and F4, respectively; mean patient age, 67.4 ± 9.7 years; 388 men and 146 women), MR images with three different section levels were augmented 90-fold (rotated, parallel-shifted, brightness-changed and contrast-changed images were generated; a total of 144 180 images). Supervised training was performed by using the DCNN model to minimize the difference between the output data (fibrosis score obtained through deep learning [FDL score]) and liver fibrosis stage. The performance of the DCNN model was evaluated in the test group (10, 10, 15, 20, and 45 patients with fibrosis stages F0, F1, F2, F3, and F4, respectively; mean patient age, 66.8 years ± 10.7; 71 male patients and 29 female patients) with receiver operating characteristic (ROC) analyses. Results The FDL score was correlated significantly with fibrosis stage (Spearman rank correlation coefficient: 0.63; P < .001). Fibrosis stages F4, F3, and F2 were diagnosed with areas under the ROC curve of 0.84, 0.84, and 0.85, respectively. Conclusion The DCNN model exhibited a high diagnostic performance in the staging of liver fibrosis. © RSNA, 2017 Online supplemental material is available for this article.
引用
- Yasaka K, Akai H, Kunimatsu A, et al. Liver Fibrosis: Deep Convolutional Neural Network for Staging by Using Gadoxetic Acid-enhanced Hepatobiliary Phase MR Images. Radiology. 2017. PMID: 29239710. doi:10.1148/radiol.2017171928
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。